(Q28165686)
Statements
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial (English)
0 references
15 October 2003
0 references
42
0 references
8
0 references
1348-56
0 references